Global Hormone Replacement Therapy Market Insights and Forecast to 2027

Publisher Name :
Date: 09-Jun-2021
No. of pages: 147
Inquire Before Buying

Hormone Replacement Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hormone Replacement Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Estrogen Hormone

- Growth Hormone

- Thyroid Hormone

- Testosterone Hormone

- The proportion of estrogen hormone in 2018 is about 50%, and the proportion is in increasing trend from 2014 to 2018.

Segment by Application

- Menopause

- Hypothyroidism

- Growth Hormone Deficiency

- Male Hypogonadism

- Other Diseases

- The most proportion of hormone replacement therapy is used in menopause, and the proportion in 2018 is 46.2%.

By Company

- Eli Lilly

- Pfizer

- AbbVie

- Novo Nordisk

- Merck KGaA

- Mylan

- Bayer

- Teva

- Novartis

- Abbott

- Roche

- Endo International

- Ipsen

- ANI Pharmaceuticals

- TherapeuticsMD

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Hormone Replacement Therapy Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Hormone Replacement Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Hormone Replacement Therapy Market Size Growth Rate by Type
1.4.2 Estrogen Hormone
1.4.3 Growth Hormone
1.2.4 Thyroid Hormone
1.2.5 Testosterone Hormone
1.3 Market by Application
1.3.1 Global Hormone Replacement Therapy Market Size Growth Rate by Application
1.3.2 Menopause
1.3.3 Hypothyroidism
1.3.4 Growth Hormone Deficiency
1.3.5 Male Hypogonadism
1.3.6 Other Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hormone Replacement Therapy Sales Estimates and Forecasts 2016-2027
2.2 Global Hormone Replacement Therapy Revenue Estimates and Forecasts 2016-2027
2.3 Global Hormone Replacement Therapy Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Hormone Replacement Therapy Regions by Sales
2.4.1 Global Top Hormone Replacement Therapy Regions by Sales (2016-2021)
2.4.2 Global Top Hormone Replacement Therapy Regions by Sales (2022-2027)
2.5 Global Top Hormone Replacement Therapy Regions by Revenue
2.5.1 Global Top Hormone Replacement Therapy Regions by Revenue (2016-2021)
2.5.2 Global Top Hormone Replacement Therapy Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hormone Replacement Therapy Sales by Manufacturers
3.1.1 Global Top Hormone Replacement Therapy Manufacturers by Sales (2016-2021)
3.1.2 Global Top Hormone Replacement Therapy Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Hormone Replacement Therapy Sales in 2020
3.2 Global Hormone Replacement Therapy Revenue by Manufacturers
3.2.1 Global Top Hormone Replacement Therapy Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Hormone Replacement Therapy Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Hormone Replacement Therapy Revenue in 2020
3.3 Global Hormone Replacement Therapy Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hormone Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hormone Replacement Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hormone Replacement Therapy Sales by Type
4.1.1 Global Hormone Replacement Therapy Historical Sales by Type (2016-2021)
4.1.2 Global Hormone Replacement Therapy Forecasted Sales by Type (2022-2027)
4.1.3 Global Hormone Replacement Therapy Sales Market Share by Type (2016-2027)
4.2 Global Hormone Replacement Therapy Revenue by Type
4.2.1 Global Hormone Replacement Therapy Historical Revenue by Type (2016-2021)
4.2.2 Global Hormone Replacement Therapy Forecasted Revenue by Type (2022-2027)
4.2.3 Global Hormone Replacement Therapy Revenue Market Share by Type (2016-2027)
4.3 Global Hormone Replacement Therapy Price by Type
4.3.1 Global Hormone Replacement Therapy Price by Type (2016-2021)
4.3.2 Global Hormone Replacement Therapy Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Hormone Replacement Therapy Sales by Application
5.1.1 Global Hormone Replacement Therapy Historical Sales by Application (2016-2021)
5.1.2 Global Hormone Replacement Therapy Forecasted Sales by Application (2022-2027)
5.1.3 Global Hormone Replacement Therapy Sales Market Share by Application (2016-2027)
5.2 Global Hormone Replacement Therapy Revenue by Application
5.2.1 Global Hormone Replacement Therapy Historical Revenue by Application (2016-2021)
5.2.2 Global Hormone Replacement Therapy Forecasted Revenue by Application (2022-2027)
5.2.3 Global Hormone Replacement Therapy Revenue Market Share by Application (2016-2027)
5.3 Global Hormone Replacement Therapy Price by Application
5.3.1 Global Hormone Replacement Therapy Price by Application (2016-2021)
5.3.2 Global Hormone Replacement Therapy Price Forecast by Application (2022-2027)
6 North America
6.1 North America Hormone Replacement Therapy Market Size by Type
6.1.1 North America Hormone Replacement Therapy Sales by Type (2016-2027)
6.1.2 North America Hormone Replacement Therapy Revenue by Type (2016-2027)
6.2 North America Hormone Replacement Therapy Market Size by Application
6.2.1 North America Hormone Replacement Therapy Sales by Application (2016-2027)
6.2.2 North America Hormone Replacement Therapy Revenue by Application (2016-2027)
6.3 North America Hormone Replacement Therapy Market Size by Country
6.3.1 North America Hormone Replacement Therapy Sales by Country (2016-2027)
6.3.2 North America Hormone Replacement Therapy Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hormone Replacement Therapy Market Size by Type
7.1.1 Europe Hormone Replacement Therapy Sales by Type (2017-2027)
7.1.2 Europe Hormone Replacement Therapy Revenue by Type (2017-2027)
7.2 Europe Hormone Replacement Therapy Market Size by Application
7.2.1 Europe Hormone Replacement Therapy Sales by Application (2017-2027)
7.2.2 Europe Hormone Replacement Therapy Revenue by Application (2017-2027)
7.3 Europe Hormone Replacement Therapy Market Size by Country
7.3.1 Europe Hormone Replacement Therapy Sales by Country (2017-2027)
7.3.2 Europe Hormone Replacement Therapy Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hormone Replacement Therapy Market Size by Type
8.1.1 Asia Pacific Hormone Replacement Therapy Sales by Type (2018-2027)
8.1.2 Asia Pacific Hormone Replacement Therapy Revenue by Type (2018-2027)
8.2 Asia Pacific Hormone Replacement Therapy Market Size by Application
8.2.1 Asia Pacific Hormone Replacement Therapy Sales by Application (2018-2027)
8.2.2 Asia Pacific Hormone Replacement Therapy Revenue by Application (2018-2027)
8.3 Asia Pacific Hormone Replacement Therapy Market Size by Region
8.3.1 Asia Pacific Hormone Replacement Therapy Sales by Region (2018-2027)
8.3.2 Asia Pacific Hormone Replacement Therapy Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hormone Replacement Therapy Market Size by Type
9.1.1 Latin America Hormone Replacement Therapy Sales by Type (2019-2027)
9.1.2 Latin America Hormone Replacement Therapy Revenue by Type (2019-2027)
9.2 Latin America Hormone Replacement Therapy Market Size by Application
9.2.1 Latin America Hormone Replacement Therapy Sales by Application (2019-2027)
9.2.2 Latin America Hormone Replacement Therapy Revenue by Application (2019-2027)
9.3 Latin America Hormone Replacement Therapy Market Size by Country
9.3.1 Latin America Hormone Replacement Therapy Sales by Country (2019-2027)
9.3.2 Latin America Hormone Replacement Therapy Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Hormone Replacement Therapy Market Size by Type
6.1.1 Middle East and Africa Hormone Replacement Therapy Sales by Type (2016-2027)
6.1.2 Middle East and Africa Hormone Replacement Therapy Revenue by Type (2016-2027)
6.2 Middle East and Africa Hormone Replacement Therapy Market Size by Application
6.2.1 Middle East and Africa Hormone Replacement Therapy Sales by Application (2016-2027)
6.2.2 Middle East and Africa Hormone Replacement Therapy Revenue by Application (2016-2027)
6.3 Middle East and Africa Hormone Replacement Therapy Market Size by Country
6.3.1 Middle East and Africa Hormone Replacement Therapy Sales by Country (2016-2027)
6.3.2 Middle East and Africa Hormone Replacement Therapy Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Eli Lilly Hormone Replacement Therapy Product Description
11.1.5 Eli Lilly Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Pfizer Hormone Replacement Therapy Product Description
11.2.5 Pfizer Related Developments
11.3 AbbVie
11.3.1 AbbVie Corporation Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 AbbVie Hormone Replacement Therapy Product Description
11.3.5 AbbVie Related Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Corporation Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Novo Nordisk Hormone Replacement Therapy Product Description
11.4.5 Novo Nordisk Related Developments
11.5 Merck KGaA
11.5.1 Merck KGaA Corporation Information
11.5.2 Merck KGaA Overview
11.5.3 Merck KGaA Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Merck KGaA Hormone Replacement Therapy Product Description
11.5.5 Merck KGaA Related Developments
11.6 Mylan
11.6.1 Mylan Corporation Information
11.6.2 Mylan Overview
11.6.3 Mylan Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Mylan Hormone Replacement Therapy Product Description
11.6.5 Mylan Related Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Overview
11.7.3 Bayer Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Bayer Hormone Replacement Therapy Product Description
11.7.5 Bayer Related Developments
11.8 Teva
11.8.1 Teva Corporation Information
11.8.2 Teva Overview
11.8.3 Teva Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Teva Hormone Replacement Therapy Product Description
11.8.5 Teva Related Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Overview
11.9.3 Novartis Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Novartis Hormone Replacement Therapy Product Description
11.9.5 Novartis Related Developments
11.10 Abbott
11.10.1 Abbott Corporation Information
11.10.2 Abbott Overview
11.10.3 Abbott Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Abbott Hormone Replacement Therapy Product Description
11.10.5 Abbott Related Developments
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Eli Lilly Hormone Replacement Therapy Product Description
11.1.5 Eli Lilly Related Developments
11.12 Endo International
11.12.1 Endo International Corporation Information
11.12.2 Endo International Overview
11.12.3 Endo International Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Endo International Product Description
11.12.5 Endo International Related Developments
11.13 Ipsen
11.13.1 Ipsen Corporation Information
11.13.2 Ipsen Overview
11.13.3 Ipsen Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Ipsen Product Description
11.13.5 Ipsen Related Developments
11.14 ANI Pharmaceuticals
11.14.1 ANI Pharmaceuticals Corporation Information
11.14.2 ANI Pharmaceuticals Overview
11.14.3 ANI Pharmaceuticals Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 ANI Pharmaceuticals Product Description
11.14.5 ANI Pharmaceuticals Related Developments
11.15 TherapeuticsMD
11.15.1 TherapeuticsMD Corporation Information
11.15.2 TherapeuticsMD Overview
11.15.3 TherapeuticsMD Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 TherapeuticsMD Product Description
11.15.5 TherapeuticsMD Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Hormone Replacement Therapy Value Chain Analysis
12.2 Hormone Replacement Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hormone Replacement Therapy Production Mode & Process
12.4 Hormone Replacement Therapy Sales and Marketing
12.4.1 Hormone Replacement Therapy Sales Channels
12.4.2 Hormone Replacement Therapy Distributors
12.5 Hormone Replacement Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hormone Replacement Therapy Industry Trends
13.2 Hormone Replacement Therapy Market Drivers
13.3 Hormone Replacement Therapy Market Challenges
13.4 Hormone Replacement Therapy Market Restraints
14 Key Findings in The Global Hormone Replacement Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Hormone Replacement Therapy Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Estrogen Hormone
Table 3. Major Manufacturers of Growth Hormone
Table 4. Major Manufacturers of Thyroid Hormone
Table 5. Major Manufacturers of Testosterone Hormone
Table 6. Global Hormone Replacement Therapy Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Hormone Replacement Therapy Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Hormone Replacement Therapy Sales by Region (2016-2021) & (K Unit)
Table 9. Global Hormone Replacement Therapy Sales Market Share by Region (2016-2021)
Table 10. Global Hormone Replacement Therapy Sales by Region (2016-2021) & (K Unit)
Table 11. Global Hormone Replacement Therapy Sales Market Share by Region (2022-2027)
Table 12. Global Hormone Replacement Therapy Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Hormone Replacement Therapy Revenue Market Share by Region (2016-2021)
Table 14. Global Hormone Replacement Therapy Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Hormone Replacement Therapy Revenue Market Share by Region (2022-2027)
Table 16. Global Hormone Replacement Therapy Sales by Manufacturers (2016-2021) & (K Unit)
Table 17. Global Hormone Replacement Therapy Sales Share by Manufacturers (2016-2021)
Table 18. Global Hormone Replacement Therapy Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Hormone Replacement Therapy Revenue Share by Manufacturers (2016-2021)
Table 20. Hormone Replacement Therapy Price by Manufacturers 2016-2021 (USD/Unit)
Table 21. Global Hormone Replacement Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Hormone Replacement Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Replacement Therapy as of 2020)
Table 23. Hormone Replacement Therapy Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Hormone Replacement Therapy Product Offered
Table 25. Date of Manufacturers Enter into Hormone Replacement Therapy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hormone Replacement Therapy Sales by Type (2016-2021) & (K Unit)
Table 28. Global Hormone Replacement Therapy Sales by Type (2022-2027) & (K Unit)
Table 29. Global Hormone Replacement Therapy Sales Share by Type (2016-2021)
Table 30. Global Hormone Replacement Therapy Sales Share by Type (2022-2027)
Table 31. Global Hormone Replacement Therapy Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Hormone Replacement Therapy Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Hormone Replacement Therapy Revenue Share by Type (2016-2021)
Table 34. Global Hormone Replacement Therapy Revenue Share by Type (2022-2027)
Table 35. Hormone Replacement Therapy Price by Type (2016-2021) & (USD/Unit)
Table 36. Global Hormone Replacement Therapy Price Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global Hormone Replacement Therapy Sales by Application (2016-2021) & (K Unit)
Table 38. Global Hormone Replacement Therapy Sales by Application (2022-2027) & (K Unit)
Table 39. Global Hormone Replacement Therapy Sales Share by Application (2016-2021)
Table 40. Global Hormone Replacement Therapy Sales Share by Application (2022-2027)
Table 41. Global Hormone Replacement Therapy Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Hormone Replacement Therapy Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Hormone Replacement Therapy Revenue Share by Application (2016-2021)
Table 44. Global Hormone Replacement Therapy Revenue Share by Application (2022-2027)
Table 45. Hormone Replacement Therapy Price by Application (2016-2021) & (USD/Unit)
Table 46. Global Hormone Replacement Therapy Price Forecast by Application (2022-2027) & (USD/Unit)
Table 47. North America Hormone Replacement Therapy Sales by Type (2016-2021) & (K Unit)
Table 48. North America Hormone Replacement Therapy Sales by Type (2022-2027) & (K Unit)
Table 49. North America Hormone Replacement Therapy Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Hormone Replacement Therapy Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Hormone Replacement Therapy Sales by Application (2016-2021) & (K Unit)
Table 52. North America Hormone Replacement Therapy Sales by Application (2022-2027) & (K Unit)
Table 53. North America Hormone Replacement Therapy Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Hormone Replacement Therapy Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Hormone Replacement Therapy Sales by Country (2016-2021) & (K Unit)
Table 56. North America Hormone Replacement Therapy Sales by Country (2022-2027) & (K Unit)
Table 57. North America Hormone Replacement Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Hormone Replacement Therapy Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Hormone Replacement Therapy Sales by Type (2016-2021) & (K Unit)
Table 60. Europe Hormone Replacement Therapy Sales by Type (2022-2027) & (K Unit)
Table 61. Europe Hormone Replacement Therapy Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Hormone Replacement Therapy Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Hormone Replacement Therapy Sales by Application (2016-2021) & (K Unit)
Table 64. Europe Hormone Replacement Therapy Sales by Application (2022-2027) & (K Unit)
Table 65. Europe Hormone Replacement Therapy Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Hormone Replacement Therapy Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Hormone Replacement Therapy Sales by Country (2016-2021) & (K Unit)
Table 68. Europe Hormone Replacement Therapy Sales by Country (2022-2027) & (K Unit)
Table 69. Europe Hormone Replacement Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Hormone Replacement Therapy Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Hormone Replacement Therapy Sales by Type (2016-2021) & (K Unit)
Table 72. Asia Pacific Hormone Replacement Therapy Sales by Type (2022-2027) & (K Unit)
Table 73. Asia Pacific Hormone Replacement Therapy Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Hormone Replacement Therapy Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Hormone Replacement Therapy Sales by Application (2016-2021) & (K Unit)
Table 76. Asia Pacific Hormone Replacement Therapy Sales by Application (2022-2027) & (K Unit)
Table 77. Asia Pacific Hormone Replacement Therapy Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Hormone Replacement Therapy Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Hormone Replacement Therapy Sales by Region (2016-2021) & (K Unit)
Table 80. Asia Pacific Hormone Replacement Therapy Sales by Region (2022-2027) & (K Unit)
Table 81. Asia Pacific Hormone Replacement Therapy Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Hormone Replacement Therapy Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Hormone Replacement Therapy Sales by Type (2016-2021) & (K Unit)
Table 84. Latin America Hormone Replacement Therapy Sales by Type (2022-2027) & (K Unit)
Table 85. Latin America Hormone Replacement Therapy Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Hormone Replacement Therapy Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Hormone Replacement Therapy Sales by Application (2016-2021) & (K Unit)
Table 88. Latin America Hormone Replacement Therapy Sales by Application (2022-2027) & (K Unit)
Table 89. Latin America Hormone Replacement Therapy Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Hormone Replacement Therapy Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Hormone Replacement Therapy Sales by Country (2016-2021) & (K Unit)
Table 92. Latin America Hormone Replacement Therapy Sales by Country (2022-2027) & (K Unit)
Table 93. Latin America Hormone Replacement Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Hormone Replacement Therapy Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Hormone Replacement Therapy Sales by Type (2016-2021) & (K Unit)
Table 96. Middle East and Africa Hormone Replacement Therapy Sales by Type (2022-2027) & (K Unit)
Table 97. Middle East and Africa Hormone Replacement Therapy Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Hormone Replacement Therapy Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Hormone Replacement Therapy Sales by Application (2016-2021) & (K Unit)
Table 100. Middle East and Africa Hormone Replacement Therapy Sales by Application (2022-2027) & (K Unit)
Table 101. Middle East and Africa Hormone Replacement Therapy Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Hormone Replacement Therapy Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Hormone Replacement Therapy Sales by Country (2016-2021) & (K Unit)
Table 104. Middle East and Africa Hormone Replacement Therapy Sales by Country (2022-2027) & (K Unit)
Table 105. Middle East and Africa Hormone Replacement Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Hormone Replacement Therapy Revenue by Country (2022-2027) & (US$ Million)
Table 107. Eli Lilly Corporation Information
Table 108. Eli Lilly Description and Major Businesses
Table 109. Eli Lilly Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Eli Lilly Hormone Replacement Therapy Product
Table 111. Eli Lilly Recent Developments
Table 112. Pfizer Corporation Information
Table 113. Pfizer Description and Major Businesses
Table 114. Pfizer Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Pfizer Hormone Replacement Therapy Product
Table 116. Pfizer Recent Developments
Table 117. AbbVie Corporation Information
Table 118. AbbVie Description and Major Businesses
Table 119. AbbVie Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. AbbVie Hormone Replacement Therapy Product
Table 121. AbbVie Recent Developments
Table 122. Novo Nordisk Corporation Information
Table 123. Novo Nordisk Description and Major Businesses
Table 124. Novo Nordisk Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Novo Nordisk Hormone Replacement Therapy Product
Table 126. Novo Nordisk Recent Developments
Table 127. Merck KGaA Corporation Information
Table 128. Merck KGaA Description and Major Businesses
Table 129. Merck KGaA Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Merck KGaA Hormone Replacement Therapy Product
Table 131. Merck KGaA Recent Developments
Table 132. Mylan Corporation Information
Table 133. Mylan Description and Major Businesses
Table 134. Mylan Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Mylan Hormone Replacement Therapy Product
Table 136. Mylan Recent Developments
Table 137. Bayer Corporation Information
Table 138. Bayer Description and Major Businesses
Table 139. Bayer Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Bayer Hormone Replacement Therapy Product
Table 141. Bayer Recent Developments
Table 142. Teva Corporation Information
Table 143. Teva Description and Major Businesses
Table 144. Teva Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Teva Hormone Replacement Therapy Product
Table 146. Teva Recent Developments
Table 147. Novartis Corporation Information
Table 148. Novartis Description and Major Businesses
Table 149. Novartis Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Novartis Hormone Replacement Therapy Product
Table 151. Novartis Recent Developments
Table 152. Abbott Corporation Information
Table 153. Abbott Description and Major Businesses
Table 154. Abbott Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. Abbott Hormone Replacement Therapy Product
Table 156. Abbott Recent Developments
Table 157. Roche Corporation Information
Table 158. Roche Description and Major Businesses
Table 159. Roche Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 160. Roche Hormone Replacement Therapy Product
Table 161. Roche Recent Developments
Table 162. Endo International Corporation Information
Table 163. Endo International Description and Major Businesses
Table 164. Endo International Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 165. Endo International Hormone Replacement Therapy Product
Table 166. Endo International Recent Developments
Table 167. Ipsen Corporation Information
Table 168. Ipsen Description and Major Businesses
Table 169. Ipsen Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 170. Ipsen Hormone Replacement Therapy Product
Table 171. Ipsen Recent Developments
Table 172. ANI Pharmaceuticals Corporation Information
Table 173. ANI Pharmaceuticals Description and Major Businesses
Table 174. ANI Pharmaceuticals Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 175. ANI Pharmaceuticals Hormone Replacement Therapy Product
Table 176. ANI Pharmaceuticals Recent Developments
Table 177. TherapeuticsMD Corporation Information
Table 178. TherapeuticsMD Description and Major Businesses
Table 179. TherapeuticsMD Hormone Replacement Therapy Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 180. TherapeuticsMD Hormone Replacement Therapy Product
Table 181. TherapeuticsMD Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Hormone Replacement Therapy Distributors List
Table 185. Hormone Replacement Therapy Customers List
Table 186. Hormone Replacement Therapy Market Trends
Table 187. Hormone Replacement Therapy Market Drivers
Table 188. Hormone Replacement Therapy Market Challenges
Table 189. Hormone Replacement Therapy Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Hormone Replacement Therapy Product Picture
Figure 2. Global Hormone Replacement Therapy Market Share by Type in 2020 & 2027
Figure 3. Estrogen Hormone Product Picture
Figure 4. Growth Hormone Product Picture
Figure 5. Thyroid Hormone Product Picture
Figure 6. Testosterone Hormone Product Picture
Figure 7. Global Hormone Replacement Therapy Sales Market Share by Application in 2020 & 2027
Figure 8. Menopause
Figure 9. Hypothyroidism
Figure 10. Growth Hormone Deficiency
Figure 11. Male Hypogonadism
Figure 12. Other Diseases
Figure 13. Hormone Replacement Therapy Report Years Considered
Figure 14. Global Hormone Replacement Therapy Sales 2016-2027 (K Unit)
Figure 15. Global Hormone Replacement Therapy Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Hormone Replacement Therapy Revenue 2016-2027 (US$ Million)
Figure 17. Global Hormone Replacement Therapy Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 18. Global Hormone Replacement Therapy Sales Market Share by Region (2016-2021)
Figure 19. Global Hormone Replacement Therapy Sales Market Share by Region (2022-2027)
Figure 20. North America Hormone Replacement Therapy Sales YoY (2016-2027) & (K Unit)
Figure 21. North America Hormone Replacement Therapy Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Europe Hormone Replacement Therapy Sales YoY (2016-2027) & (K Unit)
Figure 23. Europe Hormone Replacement Therapy Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Asia-Pacific Hormone Replacement Therapy Sales YoY (2016-2027) & (K Unit)
Fi
  • Global Hormone Replacement Therapy Market Insights and Forecast to 2027
    Published: 09-Jun-2021        Price: US 4900 Onwards        Pages: 147
    Hormone Replacement Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hormone Replacement Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Estrogen Hormone - Growth Hormone - Thyroid Hormone - Testosterone Ho......
  • 2021-2030 Report on Global Infantile Spasms Therapeutics Market by Player, Region, Type, Application and Sales Channel
    Published: 09-Jun-2021        Price: US 2500 Onwards        Pages: 104
    The global Infantile Spasms Therapeutics market was valued at $XX million in 2020, and MAResearch analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030. Since the COVID-19 virus outbreak in December 2019, the disease has spread to all countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this......
  • 2020-2025 Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 03-Jun-2021        Price: US 3360 Onwards        Pages: 103
    This report elaborates the market size, market characteristics, and market growth of the Brachytherapy Afterloaders, Brachytherapy Seeds industry, and breaks down according to the type, application, and consumption area of Brachytherapy Afterloaders, Brachytherapy Seeds. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on th......
  • 2020-2025 Global Neuromodulation Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 03-Jun-2021        Price: US 3360 Onwards        Pages: 112
    This report elaborates the market size, market characteristics, and market growth of the Neuromodulation industry, and breaks down according to the type, application, and consumption area of Neuromodulation. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industr......
  • Global Genitourinary Partnering 2010-2021: Deal trends, players and financials
    Published: 01-Jun-2021        Price: US 3495 Onwards        Pages: 400
    Global Genitourinary Partnering 2010 to 2021 provides the full collection of Genitourinary disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Genitourinary partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genitourinary partnering agreement structure Genitourinary partnering contract documents Top Genitourinary deals by value Most active Genitourinary d......
  • Global Immunology Partnering 2014-2021: Deal trends, players and financials
    Published: 01-Jun-2021        Price: US 3495 Onwards        Pages: 650
    Global Immunology Partnering 2014 to 2021 provides the full collection of Immunology disease deals signed between the world's pharmaceutical and biotechnology companies since 2014. Trends in Immunology partnering deals Financial deal terms for headline, upfront and royalty by stage of development Immunology partnering agreement structure Immunology partnering contract documents Top Immunology deals by value Most active Immunology dealmakers ......
  • Nonalcoholic Steatohepatitis - Pipeline Insight, 2021
    Published: 31-May-2021        Price: US 3000 Onwards        Pages: 230
    DelveInsight's, "Nonalcoholic Steatohepatitis - Pipeline Insight, 2021," report provides comprehensive insights about 140+ companies and 140+ pipeline drugs in Nonalcoholic Steatohepatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geograph......
  • Systemic Sclerosis - Global Drug Forecast and Market Analysis to 2030
    Published: 31-May-2021        Price: US 10995 Onwards        Pages: 160
    Systemic Sclerosis - Global Drug Forecast and Market Analysis to 2030 Summary Systemic sclerosis (SSc) is a rare, multisystem autoimmune disease that causes progressive fibrosis of the skin and internal organs, as well as vascular dysfunction. The presentation of the disease is heterogeneous, both in the organ systems affected and the overall severity of symptoms. The most common complications of SSc include digital vasculopathy (Raynaud's phenomenon and digital ulcers)......
  • Scleroderma - Pipeline Insight, 2021
    Published: 31-May-2021        Price: US 2500 Onwards        Pages: 100
    DelveInsight's, "Scleroderma - Pipeline Insight, 2021," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Scleroderma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global coverage......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected]rmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs